NASDAQ Small Stocks with Sharp Volumes: (NASDAQ: LNET), (NASDAQ:IVAN), (NASDAQ: CRME), (NASDAQ:SCON)

By anotherwinningtrade

Houston, TX –December 14, 2012 — (Net PR News) – AnotherWinningTrade.com, the leader for breaking information and up-to-date market activities on Wall Street, locates high-growth equity opportunities. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com .

Today’s focus is on: LNET, IVAN, CRME, SCON

LodgeNet Interactive Corp. (NASDAQ:LNET) remained a bull for the day as it reported upward momentum of 11.57% and closed at $0.135 after gaining total volume of 2,910,368 shares.

LNET has the total of 26.83 million outstanding shares and its total market capitalization is $3.62 million.

The Company’s year to date performance remained quite optimistic with the gain of -94.35%, while in the last 6 months it lost almost -90.43%. During the last three months, the company reported a downturn momentum of -68.24%.

How Should Investors Trade LNET Now? Don’t Trade LNET Until You Read This TREND ANALYSIS REPORT

Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN) ended its day in the gaining stream with the gain of 1.22% and closed at the price of $0.810 after opening at $0.78. The stock traded during its last trading session with the total volume of 1,744,100 shares as compared to its average volume of 1.68 million shares.

During the previous session, the company’s minimum price was $0.75 while it touched its highest price for the day at $0.81. IVAN’s beta value stands at 2.19 points.

During the last one month, the company gained 1.22% while its last 5 days shows an upsurge of 72.34%.

How Should Investors React To IVAN Now? Find Out In This TREND ANALYSIS REPORT

CARDIOME PHARMA CORP (NASDAQ:CRME) traded with a decrease of -7.95% and closed at $0.377 after gaining total volume of 1,306,400 share.s Its opening price was $0.42.

CARDIOME PHARMA’s EPS is $-0.52 while its beta value stands at 1.24 times.

If we look at the previous 5 day’s performance of the stock, it remained optimistic with the gain of 38.35% and in its last one month’s trade it gained 30.04%.

CRME has total market capitalization of $23.02 million and a total of 61.13 million outstanding shares.

CARDIOME PHARMA CORP (NASDAQ: CRME) has updated that it has entered into a deal with Merck. The deal is made for settling its debt commitments stemming from the company’s collaboration and license contract for vernakalant, in which company had entered in April 2009.

Cardiome Pharma Corp., (NASDAQ: CRME) focuses on the discovery, development, and commercialization of drugs to treat or prevent cardiovascular and other diseases.

Get A Free Report And Detailed Analysis On CRME CLICK HERE To Read

Superconductor Technologies, Inc. (NASDAQ:SCON) remained among the day’s losers and traded with volume of 3,824,400 shares in the last session as compared to average volume of 431,206.00 shares.

The stock on Thursday decreased -17.01% and finished the day at $0.336. SCON was a loser in its 5 days activity and slipped about -1.18%. The one month performance of the stock was negative and it plunged more than -19%. The 52 week range of the stock remained $0.25 – $1.77.

Superconductor Technologies, Inc. (NASDAQ: SCON) has made an announcement regarding the price factor of a registered direct offering. The offering is of 6,250,000 common stocks at an offering price of $0.32 for each stock. There are prospects of about $2.0 million, as gross earnings from the offering, after subtracting the expected offering expenses.

SCON engages in the development and production of high temperature superconducting materials along with associated technologies.

Is SCON A Solid Investment At These Levels? Find Out Exactly Where SCON Is Headed With This TREND ANALYSIS REPORT

Disclaimer:

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.